Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition

Clinical trial NCT03508739 · SUSPENDED

Trial details

NCT number: NCT03508739
Sponsor: University of Pennsylvania
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus, Type 2 Pre-diabetic Hypertension Elevated Blood Pressure

Start date: 2018-06-01
Primary completion: 2026-06-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.